India is cutting cancer drug prices by up to 70% after adding 137 non-scheduled anti-cancer medicines to its price control list. The move aims to make treatment more affordable in the country’s $2.6 billion oncology market, according to a statement from the Ministry of Chemicals and Fertilisers. Margins capped across all formulations The medicines include immunotherapy drugs used for 20…